BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 20660388)

  • 21. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors.
    Frilling A; Sotiropoulos GC; Radtke A; Malago M; Bockisch A; Kuehl H; Li J; Broelsch CE
    Ann Surg; 2010 Nov; 252(5):850-6. PubMed ID: 21037441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
    Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
    Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration.
    Hofmann M; Steinke F; Scheel V; Charpiat G; Farquhar J; Aschoff P; Brady M; Schölkopf B; Pichler BJ
    J Nucl Med; 2008 Nov; 49(11):1875-83. PubMed ID: 18927326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI-Based Attenuation Correction for PET/MRI Using Multiphase Level-Set Method.
    An HJ; Seo S; Kang H; Choi H; Cheon GJ; Kim HJ; Lee DS; Song IC; Kim YK; Lee JS
    J Nucl Med; 2016 Apr; 57(4):587-93. PubMed ID: 26697962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
    Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shine-Through in PET/MR Imaging: Effects of the Magnetic Field on Positron Range and Subsequent Image Artifacts.
    Kolb A; Sauter AW; Eriksson L; Vandenbrouke A; Liu CC; Levin C; Pichler BJ; Rafecas M
    J Nucl Med; 2015 Jun; 56(6):951-4. PubMed ID: 25766897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Software-based PET-MR image coregistration: combined PET-MRI for the rest of us!
    Robertson MS; Liu X; Plishker W; Zaki GF; Vyas PK; Safdar NM; Shekhar R
    Pediatr Radiol; 2016 Oct; 46(11):1552-61. PubMed ID: 27380195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance-based attenuation correction for PET/MR hybrid imaging using continuous valued attenuation maps.
    Navalpakkam BK; Braun H; Kuwert T; Quick HH
    Invest Radiol; 2013 May; 48(5):323-32. PubMed ID: 23442772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined PET/MR imaging using (68)Ga-DOTATOC for radiotherapy treatment planning in meningioma patients.
    Thorwarth D; Müller AC; Pfannenberg C; Beyer T
    Recent Results Cancer Res; 2013; 194():425-39. PubMed ID: 22918773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
    Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
    J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory motion correction in oncologic PET using T1-weighted MR imaging on a simultaneous whole-body PET/MR system.
    Würslin C; Schmidt H; Martirosian P; Brendle C; Boss A; Schwenzer NF; Stegger L
    J Nucl Med; 2013 Mar; 54(3):464-71. PubMed ID: 23287577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
    Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 13N-Ammonia PET/CT for detection of recurrent glioma: a prospective comparison with contrast-enhanced MRI.
    Khangembam BC; Sharma P; Karunanithi S; Singhal A; Das CJ; Kumar P; Julka PK; Bandopadhyaya GP; Kumar R; Malhotra A; Bal C
    Nucl Med Commun; 2013 Nov; 34(11):1046-54. PubMed ID: 24025920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of simultaneous PET/MR imaging in the head and upper neck area.
    Boss A; Stegger L; Bisdas S; Kolb A; Schwenzer N; Pfister M; Claussen CD; Pichler BJ; Pfannenberg C
    Eur Radiol; 2011 Jul; 21(7):1439-46. PubMed ID: 21308378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of time-of-flight PET on quantification errors in MR imaging-based attenuation correction.
    Mehranian A; Zaidi H
    J Nucl Med; 2015 Apr; 56(4):635-41. PubMed ID: 25745090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small animal simultaneous PET/MRI: initial experiences in a 9.4 T microMRI.
    Maramraju SH; Smith SD; Junnarkar SS; Schulz D; Stoll S; Ravindranath B; Purschke ML; Rescia S; Southekal S; Pratte JF; Vaska P; Woody CL; Schlyer DJ
    Phys Med Biol; 2011 Apr; 56(8):2459-80. PubMed ID: 21441651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
    Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.